{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T12:09:18Z","timestamp":1784117358368,"version":"3.55.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.modpat.2026.101016","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:49:30Z","timestamp":1779346170000},"page":"101016","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Genetic Profile, Treatment Response, and Outcomes of BCR::ABL1-Positive Mixed-Phenotype Acute Leukemia: A Study From the BCR::ABL1 Pathology Group"],"prefix":"10.1016","volume":"39","author":[{"given":"Qiudan","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Shuai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellias","family":"Jabbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weina","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrnoosh","family":"Tashakori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Khanlari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siba","family":"El Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergej","family":"Konoplev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph D.","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa A.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7110-3814","authenticated-orcid":false,"given":"Shimin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.modpat.2026.101016_bib1","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1182\/blood-2010-10-314682","article-title":"Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification","volume":"117","author":"Matutes","year":"2011","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.modpat.2026.101016_bib2","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3324\/haematol.2012.064485","article-title":"Clinical, immunophenotypic, cytogenetic, and molecular genetic features in 117 adult patients with mixed-phenotype acute leukemia defined by WHO-2008 classification","volume":"97","author":"Yan","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.modpat.2026.101016_bib3","series-title":"WHO Classification of Tumours. Haematolymphoid Tumours","year":"2024"},{"issue":"7727","key":"10.1016\/j.modpat.2026.101016_bib4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41586-018-0436-0","article-title":"The genetic basis and cell of origin of mixed phenotype acute leukaemia","volume":"562","author":"Alexander","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.modpat.2026.101016_bib5","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1038\/s41467-018-04924-z","article-title":"Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes","volume":"9","author":"Takahashi","year":"2018","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.modpat.2026.101016_bib6","doi-asserted-by":"crossref","first-page":"8191","DOI":"10.1038\/s41467-024-52317-2","article-title":"Multiomic single cell sequencing identifies stemlike nature of mixed phenotype acute leukemia","volume":"15","author":"Peretz","year":"2024","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.modpat.2026.101016_bib7","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.modpat.2026.101016_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/ejh.13413","article-title":"Mixed phenotype acute leukemia: biological profile, clinical characteristic and treatment outcomes: report of the population-based study","volume":"105","author":"Zaj\u0105c-Spycha\u0142a","year":"2020","journal-title":"Eur J Haematol"},{"issue":"6","key":"10.1016\/j.modpat.2026.101016_bib9","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1309\/AJCPPVUPOTUVOIB5","article-title":"Mixed phenotype acute leukemia: a study of 61 cases using World Health Organization and European Group for the Immunological Classification of Leukaemias criteria","volume":"142","author":"Weinberg","year":"2014","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.modpat.2026.101016_bib10","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s12185-011-0953-1","article-title":"Clinical characteristics and outcomes of mixed phenotype acute leukemia with Philadelphia chromosome positive and\/or bcr-abl positive in adult","volume":"94","author":"Wang","year":"2011","journal-title":"Int J Hematol"},{"issue":"4","key":"10.1016\/j.modpat.2026.101016_bib11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/ejh.12343","article-title":"Philadelphia chromosome-positive mixed phenotype acute leukemia in the imatinib era","volume":"93","author":"Shimizu","year":"2014","journal-title":"Eur J Haematol"},{"issue":"16","key":"10.1016\/j.modpat.2026.101016_bib12","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1182\/blood-2014-10-551465","article-title":"How I treat mixed-phenotype acute leukemia","volume":"125","author":"Wolach","year":"2015","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.modpat.2026.101016_bib13","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11899-018-0474-6","article-title":"Chronic myeloid leukemia: beyond BCR-ABL1","volume":"13","author":"Zhou","year":"2018","journal-title":"Curr Hematol Malig Rep"},{"issue":"19","key":"10.1016\/j.modpat.2026.101016_bib14","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1182\/blood.2023020794","article-title":"Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel","volume":"143","author":"G\u00f6kbuget","year":"2024","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.modpat.2026.101016_bib15","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.leukres.2011.04.011","article-title":"Incidence of Philadelphia-chromosome in acute myelogenous leukemia and biphenotypic acute leukemia patients: and its role in their outcome","volume":"35","author":"Atfy","year":"2011","journal-title":"Leuk Res"},{"key":"10.1016\/j.modpat.2026.101016_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2025.107665","article-title":"Molecular genetic characterization of mixed-phenotype acute leukemia (MPAL) with BCR::ABL1 fusion","volume":"151","author":"Shi","year":"2025","journal-title":"Leuk Res"},{"issue":"1","key":"10.1016\/j.modpat.2026.101016_bib17","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3109\/10428194.2012.701739","article-title":"Molecular characterization of de novo Philadelphia chromosome-positive acute myeloid leukemia","volume":"54","author":"Konoplev","year":"2013","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.modpat.2026.101016_bib18","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1038\/s41467-021-23097-w","article-title":"Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemia","volume":"12","author":"Ochi","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.modpat.2026.101016_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41408-024-00983-2","article-title":"Genetics and pathologic landscape of lineage switch of acute leukemia during therapy","volume":"14","author":"Zhou","year":"2024","journal-title":"Blood Cancer J"},{"issue":"9","key":"10.1016\/j.modpat.2026.101016_bib20","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.3390\/cancers17091436","article-title":"Clinical utility of optical genome mapping as an additional tool in a standard cytogenetic workup in hematological malignancies","volume":"17","author":"Toruner","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.modpat.2026.101016_bib21","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3324\/haematol.2013.093765","article-title":"Next-generation sequencing-based multigene mutational screening for acute myeloid leukemia using MiSeq: applicability for diagnostics and disease monitoring","volume":"99","author":"Luthra","year":"2014","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.modpat.2026.101016_bib22","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1056\/NEJMoa1112304","article-title":"Prognostic relevance of integrated genetic profiling in acute myeloid leukemia","volume":"366","author":"Patel","year":"2012","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.modpat.2026.101016_bib23","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.modpat.2026.101016_bib24","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Ley","year":"2013","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.modpat.2026.101016_bib25","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/s41588-022-01159-z","article-title":"The genomic landscape of pediatric acute lymphoblastic leukemia","volume":"54","author":"Brady","year":"2022","journal-title":"Nat Genet"},{"issue":"50","key":"10.1016\/j.modpat.2026.101016_bib26","doi-asserted-by":"crossref","first-page":"E11711","DOI":"10.1073\/pnas.1814397115","article-title":"Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases","volume":"115","author":"Li","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.modpat.2026.101016_bib27","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41588-018-0315-5","article-title":"PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia","volume":"51","author":"Gu","year":"2019","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.modpat.2026.101016_bib28","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/hon.2416","article-title":"Interphase FISH for BCR-ABL1 rearrangement on neutrophils: a decisive tool to discriminate a lymphoid blast crisis of chronic myeloid leukemia from a de novo BCR-ABL1 positive acute lymphoblastic leukemia","volume":"36","author":"Balducci","year":"2018","journal-title":"Hematol Oncol"},{"issue":"12","key":"10.1016\/j.modpat.2026.101016_bib29","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1080\/10428194.2020.1795160","article-title":"Chronic myeloid leukemia presenting in lymphoblastic crisis, a differential diagnosis with Philadelphia-positive B-lymphoblastic leukemia","volume":"61","author":"Chen","year":"2020","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"10.1016\/j.modpat.2026.101016_bib30","first-page":"795","article-title":"Lineage involvement by BCR\/ABL in Ph+ lymphoblastic leukemias: chronic myelogenous leukemia presenting in lymphoid blast vs Ph+ acute lymphoblastic leukemia","volume":"10","author":"Anastasi","year":"1996","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.modpat.2026.101016_bib31","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/s41375-025-02609-3","article-title":"Somatic mutations and outcomes in chronic myeloid leukemia adolescent and young adults compared to children, adults, and BCR::ABL1-positive acute lymphoblastic leukemia","volume":"39","author":"Krizkova","year":"2025","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.modpat.2026.101016_bib32","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/gcc.22936","article-title":"Clinical and genomic characterization of patients diagnosed with the provisional entity acute myeloid leukemia with BCR-ABL1, a Swedish population-based study","volume":"60","author":"Orsmark-Pietras","year":"2021","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"10.1016\/j.modpat.2026.101016_bib33","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/ajh.26758","article-title":"Integrative genomic and transcriptomic profiling reveals distinct molecular subsets in adult mixed phenotype acute leukemia","volume":"98","author":"Wang","year":"2023","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.modpat.2026.101016_bib34","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/ijc.27964","article-title":"RUNX family: regulation and diversification of roles through interacting proteins","volume":"132","author":"Chuang","year":"2013","journal-title":"Int J Cancer"},{"issue":"15","key":"10.1016\/j.modpat.2026.101016_bib35","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1182\/blood-2016-10-687830","article-title":"Role of RUNX1 in hematological malignancies","volume":"129","author":"Sood","year":"2017","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.modpat.2026.101016_bib36","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/s41375-020-01011-5","article-title":"RUNX1 mutations in blast-phase chronic myeloid leukemia associate with distinct phenotypes, transcriptional profiles, and drug responses","volume":"35","author":"Adnan Awad","year":"2021","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.modpat.2026.101016_bib37","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/s41375-018-0058-4","article-title":"Therapy for children and adults with mixed phenotype acute leukemia: a systematic review and meta-analysis","volume":"32","author":"Maruffi","year":"2018","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.modpat.2026.101016_bib38","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1007\/s00277-020-04179-z","article-title":"Favorable outcomes of acute leukemias of ambiguous lineage treated with hyperCVAD: a multi-center retrospective study","volume":"99","author":"Duong","year":"2020","journal-title":"Ann Hematol"},{"issue":"3","key":"10.1016\/j.modpat.2026.101016_bib39","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/cncr.32552","article-title":"Mixed-phenotype acute leukemia: a cohort and consensus research strategy from the Children\u2019s Oncology Group Acute Leukemia of Ambiguous Lineage Task Force","volume":"126","author":"Orgel","year":"2020","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.modpat.2026.101016_bib40","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00277-020-04354-2","article-title":"Acute lymphoblastic leukemia\u2013like treatment regimen provides better response in mixed phenotype acute leukemia: a comparative study between adults and pediatric MPAL patients","volume":"100","author":"Rasekh","year":"2021","journal-title":"Ann Hematol"},{"issue":"5","key":"10.1016\/j.modpat.2026.101016_bib41","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s00277-023-05162-0","volume":"102","author":"Lazzarotto","year":"2023","journal-title":"Ann Hematol"},{"issue":"11","key":"10.1016\/j.modpat.2026.101016_bib42","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1038\/leu.2016.126","article-title":"RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features","volume":"30","author":"Gaidzik","year":"2016","journal-title":"Leukemia"},{"issue":"18","key":"10.1016\/j.modpat.2026.101016_bib43","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1182\/blood.2024026273","article-title":"Defining 2 biologically and clinically distinct groups in acute leukemia with a mixed phenotype","volume":"145","author":"Galera","year":"2025","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.modpat.2026.101016_bib44","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.bbmt.2017.06.026","article-title":"Allogeneic hematopoietic stem cell transplantation with myeloablative conditioning is associated with favorable outcomes in mixed phenotype acute leukemia","volume":"23","author":"Getta","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1016\/j.modpat.2026.101016_bib45","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.3324\/haematol.2017.174441","article-title":"Mixed phenotype acute leukemia: outcomes with allogeneic stem cell transplantation. A retrospective study from the Acute Leukemia Working Party of the EBMT","volume":"102","author":"Munker","year":"2017","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.modpat.2026.101016_bib46","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/ejh.12516","article-title":"Allogeneic hematopoietic stem cell transplantation for adult patients with mixed phenotype acute leukemia: results of a matched-pair analysis","volume":"95","author":"Shimizu","year":"2015","journal-title":"Eur J Haematol"},{"issue":"2","key":"10.1016\/j.modpat.2026.101016_bib47","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00277-015-2536-3","article-title":"Outcomes of allogeneic hematopoietic cell transplantation in patients with biphenotypic acute leukemia","volume":"95","author":"Mori","year":"2016","journal-title":"Ann Hematol"},{"issue":"6","key":"10.1016\/j.modpat.2026.101016_bib48","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.bbmt.2016.02.013","article-title":"Allogeneic hematopoietic cell transplantation for patients with mixed phenotype acute leukemia","volume":"22","author":"Munker","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.modpat.2026.101016_bib49","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1038\/s41375-025-02664-w","article-title":"2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia","volume":"39","author":"Apperley","year":"2025","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.modpat.2026.101016_bib50","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1038\/s41409-021-01410-x","article-title":"Risk factors for outcome after allogeneic stem cell transplantation in patients with advanced phase CML","volume":"56","author":"Niederwieser","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.modpat.2026.101016_bib51","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2141.1979.tb01161.x","article-title":"Ph1-positive acute leukaemia and chronic granulocytic leukaemia: one or two diseases?","volume":"42","author":"Catovsky","year":"1979","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.modpat.2026.101016_bib52","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/ajh.27210","article-title":"Recurrent lymphoid and myeloid relapses due to treatment cessations reveal natural history of Ph-positive B-ALL and pose a diagnostic challenge","volume":"99","author":"Hu","year":"2024","journal-title":"Am J Hematol"},{"issue":"20","key":"10.1016\/j.modpat.2026.101016_bib53","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1182\/blood-2016-11-749978","article-title":"Monitoring of childhood ALL using BCR-ABL1 genomic breakpoints identifies a subgroup with CML-like biology","volume":"129","author":"Hovorkova","year":"2017","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.modpat.2026.101016_bib54","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1182\/blood-2017-05-782888","article-title":"Hematopoietic stem cell involvement in BCR-ABL1-positive ALL as a potential mechanism of resistance to blinatumomab therapy","volume":"130","author":"Nagel","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.modpat.2026.101016_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.586567","article-title":"Multi-lineage BCR-ABL expression in Philadelphia chromosome-positive acute lymphoblastic leukemia is associated with improved prognosis but no specific molecular features","volume":"10","author":"Nishiwaki","year":"2020","journal-title":"Front Oncol"},{"issue":"12","key":"10.1016\/j.modpat.2026.101016_bib56","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1038\/s41375-022-01668-0","article-title":"Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease","volume":"36","author":"Zuna","year":"2022","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.modpat.2026.101016_bib57","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nm1253","article-title":"Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia","volume":"11","author":"Castor","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.modpat.2026.101016_bib58","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2025.300254","article-title":"CML-like biology is a unifying feature of myeloid\/lymphoid neoplasms with tyrosine kinase fusions in lymphoid blast phase. Comment on: Multilineage involvement in ABL-class fusion-positive pediatric B-cell acute lymphoblastic leukemia: CML-like biology","author":"Wang","year":"2026","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.modpat.2026.101016_bib59","doi-asserted-by":"crossref","first-page":"919","DOI":"10.3324\/haematol.2008.003202","article-title":"Clinical and biological characteristics of adult biphenotypic acute leukemia in comparison with that of acute myeloid leukemia and acute lymphoblastic leukemia: a case series of a Chinese population","volume":"94","author":"Xu","year":"2009","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.modpat.2026.101016_bib60","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/sj.leu.2404128","article-title":"Cytogenetics, molecular and ultrastructural characteristics of biphenotypic acute leukemia identified by the EGIL scoring system","volume":"20","author":"Owaidah","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.modpat.2026.101016_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2023.107309","article-title":"Acute leukemias with complex karyotype show a similarly poor outcome independent of mixed, myeloid or lymphoblastic immunophenotype: a study from the Bone Marrow Pathology Group","volume":"130","author":"Kirtek","year":"2023","journal-title":"Leuk Res"},{"issue":"1","key":"10.1016\/j.modpat.2026.101016_bib63","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ajh.70133","article-title":"Mixed-phenotype acute leukemia with mutated TP53: genetic landscape, therapeutic response, and outcomes","volume":"101","author":"Wang","year":"2026","journal-title":"Am J Hematol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226000591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226000591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T11:22:30Z","timestamp":1784114550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395226000591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":62,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0893395226000591"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101016","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic Profile, Treatment Response, and Outcomes of BCR::ABL1-Positive Mixed-Phenotype Acute Leukemia: A Study From the BCR::ABL1 Pathology Group","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 THE AUTHORS. Published by Elsevier Inc. on behalf of the United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}],"article-number":"101016"}}